Interferon-α/β Receptor as a Prognostic. Marker in Osteosarcoma

Kubo, Tadahiko; Shimose, Shoji; Matsuo, Toshihiro; Fujimori, Jun; Arihiro, Koji; Ochi, Mitsuo
March 2011
Journal of Bone & Joint Surgery, American Volume;3/16/2011, Vol. 93-A Issue 6, p519
Academic Journal
Background: A large-scale randomized trial of adjuvant interferon-α therapy for patients with osteosarcoma has been initiated as a joint protocol by the European and American Osteosarcoma Study Group. Because the expression of functional interferon-α/β receptor is necessary for interferon-a agents to interact with osteosarcoma cells, we examined the expression of interferonα/β receptor in a series of osteosarcoma specimens. Methods: Forty patients with high-grade resectable osteosarcoma, from whom surgical specimens had been obtained at the time of biopsy, were included in this retrospective study. Biopsy specimens were immunohistochemically stained with anti-interferon-a/13 receptor antibodies. Survival was estimated with the Kaplan-Meier method. The Cox proportional hazards model was used for multivariate analysis to determine the independent prognostic factors. Furthermore, we used Holm and Benjamini-Hochberg procedures to adjust for multiple comparisons in setting the level of significance. The median follow-up period was five years and two months (range, four to 195 months). Results: The expression of interferon-a/13 receptor was positive in eighteen (45%) of the forty patients with high-grade osteosarcoma. American Joint Committee on Cancer surgical stage HA, a good histologic response to chemotherapy, and expression of interferon-a/13 receptor correlated significantly with better disease-free survival (p < 0.05). Multivariate analysis showed that interferon-a/13 receptor expression alone retained its power to predict an improved prognosis (p = 0.042). There were no significant variables after corrections for multiple comparisons. Conclusions: lnterferon-a/3 receptor may be a useful marker for assessing tumor prognosis in patients with osteosarcoma and may play an important role in tumor progression. These findings are encouraging and support the ongoing clinical trials of adjuvant interferon-a therapy by the multinational Osteosarcoma Study Group. Our pilot study was based on a small sample size, and larger trials are needed to confirm this finding.


Related Articles

  • The Number of Resected Lymph Nodes (nLNs) Combined with Tumor Size as a Prognostic Factor in Patients with Pathologic N0 and Nx Non-Small Cell Lung Cancer. Yang, Miaomiao; Cao, Hongxin; Guo, Xi; Zhang, Tiehong; Hu, Pingping; Du, Jiajun; Liu, Qi // PLoS ONE;Sep2013, Vol. 8 Issue 9, p1 

    Background: The prognostic role of the number of resected lymph nodes (nLNs) in pathologic N0 (lymph node negative) and Nx (no lymph node examined) non-small cell lung cancer (NSCLC) patients remains uncertain. Guidelines for optimal nLNs have not been established. In the current study, we...

  • Papillary carcinoma of the thyroid in Japan: subclassification of common type and identification of low risk group. Kakudo, K.; Tang, W.; Ito, Y.; Mori, I.; Nakamura, Y.; Miyauchi, A. // Journal of Clinical Pathology;Oct2004, Vol. 57 Issue 10, p1041 

    Aims: Papillary thyroid carcinoma (FTC) is classified into two subgroups--common type and other histological variants. Correlations between further subgrouping of the common type and patient prognosis are not well documented. Aims: To introduce two novel histological parameters to characterise...

  • MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. GANG HAN; YAN WANG; WENZHI BI; JINPENG JIA; WEI WANG // Experimental & Therapeutic Medicine;2015, Vol. 9 Issue 3, p679 

    MicroRNA-124 (miR-124) has been demonstrated to be downregulated in numerous human malignancies and correlated with tumor progression. However, its expression and clinical significance in osteosarcoma remains unclear. Thus, the aim of the present study was to explore the effects of miR-124 in...

  • Fifteen Years' Experience of the Brazilian Osteosarcoma Treatment Group (BOTG): A Contribution from an Emerging Country. Petrilli, Antonio Sergio; Brunetto, Algemir Lunardi; Cypriano, Monica dos Santos; Ferraro, Alexandre Archanjo; Donato Macedo, Carla Renata Pacheco; Senerchia, Andreza Almeida; Almeida, Maria Teresa; Costa, Cecilia Maria da; Lustosa, Daniel; Borsato, Maria Luiza; Calheiros, Luiz Mario; Barreto, Jose Henrique Silva; Epelman, Sidnei; Carvalho, Eny; Alves, Maria Teresa Seixas; Petrilli, Marcelo de Toledo; Penna, Valter; Pericles, Pedro; de Camargo, Olavo Pires; Garcia-Filho on behalf of th // Journal of Adolescent & Young Adult Oncology;Dec2013, Vol. 2 Issue 4, p145 

    Purpose: Little information is available regarding the tumor features, prognostic factors, and treatment results in children and adolescents and young adults (AYAs) with osteosarcoma diagnosed in developing countries. We reviewed the results of three observational cohorts of osteosarcoma...

  • Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan. Suzuki, Fumitaka; Arase, Yasuji; Suzuki, Yoshiyuki; Akuta, Norio; Sezaki, Hitomi; Seko, Yuya; Kawamura, Yusuke; Hosaka, Tetsuya; Kobayashi, Masahiro; Saito, Satoshi; Ikeda, Kenji; Kobayashi, Mariko; Kumada, Hiromitsu // Journal of Gastroenterology;Jul2012, Vol. 47 Issue 7, p814 

    Background: Few studies have investigated the long-term effects of interferon (IFN) therapy for chronic hepatitis B (CHB). In this retrospective study, we investigated the efficacy of and predictors of response to IFN therapy in CHB patients. Methods: We analyzed data for 615 Japanese CHB...

  • Prognostic implication of F FDG-PET in patients with extrahepatic metastatic hepatocellular carcinoma undergoing systemic treatment, a retrospective cohort study. Shin, Dong-Yeop; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue // Cancer Chemotherapy & Pharmacology;Jul2011, Vol. 68 Issue 1, p165 

    Purpose: The role of F FDG-PET in hepatocellular carcinoma (HCC) has not been firmly established. We conducted this study to investigate the clinical implication of SUVmax on F FDG-PET as a prognostic factor in patients with HCC, especially in the metastatic setting. Methods: HCC patients with...

  • Gastroenteropancreatic neuroendocrine tumors: 10-year experience in a single center. Yildiz, Ozcan; Ozguroglu, Mustafa; Yanmaz, Teoman; Turna, Hande; Serdengecti, Suheyla; Dogusoy, Gulen // Medical Oncology;Dec2010, Vol. 27 Issue 4, p1050 

    Neuroendocrine tumors originate from neuroendocrine cells and occur in a wide spectrum from carcinoid tumors to small cell carcinomas. Although the World Health Organization determined clinical and histological features to predict prognosis for such tumors, they may not be valid on an individual...

  • Usefulness of the Log Odds of Positive Lymph Nodes to Predict and Discriminate Prognosis in Gastric Carcinomas. Calero, A.; Escrig-Sos, J.; Mingol, F.; Arroyo, A.; Martinez-Ramos, D.; Juan, M.; Salvador-Sanchis, J.; Garcia-Granero, E.; Calpena, R.; Lacueva, F. // Journal of Gastrointestinal Surgery;May2015, Vol. 19 Issue 5, p813 

    Background: The lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS) have been proposed to minimize the stage migration phenomenon. The value of the LODDS and LNR staging systems to predict and discriminate prognosis was assessed and compared to the International Union Against...

  • Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. Wang, Yan-Na; Shen, Kun-Tang; Ling, Jia-Qian; Gao, Xiao-Dong; Hou, Ying-Yong; Wang, Xue-Fei; Jing Qin; Sun, Yi-Hong; Qin, Xin-Yu // BMC Surgery;2012, Vol. 12 Issue 1, p1 

    Background: Gastric cancer with synchronous liver metastasis remains a clinical treatment challenge. There has been a longstanding debate on the question whether surgical resection could be beneficial to long-term survival. This study is to investigate the effectiveness and prognostic factors of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics